MS-325 berlex phase 2008 Pages on BioPortfolio:

BioPortfolio - Berlex Laboratories Incorporated
Recent Publications by Berlex Laboratories Incorporated:. A summary of safety of gadofosveset (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase ...
http://www.bioportfolio.com/biocorporate/1337-Berlex_Laborat...

BioPortfolio - Berlex Laboratories Incorporated - Profile
... (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase ... The Business Journal Phoenix: Oct 15 2008 2:31PM Matching: berlex laboratories ...
http://www.bioportfolio.com/biocorporate/1337-Berlex%252BLab...

BioPortfolio - Berlex Laboratories Incorporated - Profile
... (MS-325) at 0.03 mmol/kg body weight dose: Phase II and Phase ... Baltimore Business Journal: Nov 14 2008 4:55AM Matching: berlex laboratories ...
http://www.bioportfolio.com/biocorporate/1337-Berlex+Laborat...

Results from other life science and pharmaceutical sites:

A summary of safety of gadofosveset (MS-325) at 0....[Invest ...
2008]; MR angiography of aortoiliac occlusive disease: a phase III study of the safety and effectiveness of the blood-pool contrast agent MS-325. ...
http://www.ncbi.nlm.nih.gov/pubmed/17035873...

{1} And {2} Get EU Vasovist OK - News, Search Jobs, Events
In the four multi center Phase III clinical trials Vasovist(R) showed a ... Media Relations: Heather Levis, T:+1-973-305-5313, heather_levis@berlex.com ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2135032...

Journal of Cerebral Blood Flow & Metabolism - Quantitative ...
R2* from the last 20 scans (plateau phase of hypercapnia) were averaged. ..... obtained between this study and our previous study in which MS-325 was used. ...
http://www.nature.com/jcbfm/journal/v19/n8/full/9590580a.htm...

DIVIDENDS THE SCHERING AG GROUP
in the United States and Canada under the Berlex trade name. ...... Status. SHU 555 C. MRI contrast agent/cardiovascular. Phase III. MS-325 ...
http://www.schering.de/html/en/50_media/download/_files/2004...

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.